These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27904864)

  • 1. Nephrotic-Range Proteinuria and Peripheral Edema in a Child: Not Only Idiopathic Nephrotic Syndrome.
    Dolcemascolo V; Vivarelli M; Colucci M; Diomedi-Camassei F; Piras R; Alberti M; Emma F
    Case Rep Nephrol Dial; 2016; 6(3):120-127. PubMed ID: 27904864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical hemolytic uremic syndrome.
    Loirat C; Frémeaux-Bacchi V
    Orphanet J Rare Dis; 2011 Sep; 6():60. PubMed ID: 21902819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical Hemolytic Uremic Syndrome in a Pregnant Patient with a Thrombomodulin Gene Variant Treated with Plasma Exchange and Eculizumab.
    Kannan L
    Am J Case Rep; 2023 Apr; 24():e938896. PubMed ID: 37120715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical Hemolytic Uremic Syndrome and Chronic Ulcerative Colitis Treated with Eculizumab.
    Webb TN; Griffiths H; Miyashita Y; Bhatt R; Jaffe R; Moritz M; Hofer J; Swiatecka-Urban A
    Int J Med Pharm Case Reports; 2015; 4(5):105-112. PubMed ID: 27135055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atypical hemolytic uremic syndrome].
    Blasco Pelicano M; Rodríguez de Córdoba S; Campistol Plana JM
    Med Clin (Barc); 2015 Nov; 145(10):438-45. PubMed ID: 25433773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathophysiology of atypical hemolytic uremic syndrome. Ten years of progress, from laboratory to patient].
    Frémeaux-Bacchi V
    Biol Aujourdhui; 2013; 207(4):231-40. PubMed ID: 24594571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Ito S; Hidaka Y; Inoue N; Kaname S; Kato H; Matsumoto M; Miyakawa Y; Mizuno M; Okada H; Shimono A; Matsuda T; Maruyama S; Fujimura Y; Nangaku M; Kagami S
    Clin Exp Nephrol; 2019 Jan; 23(1):112-121. PubMed ID: 30039480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Eculizumab for the treatment of atypical hemolytic uremic syndrome: case report and revision of the literature].
    Vaisbich MH; Henriques Ldos S; Watanabe A; Pereira LM; Metran CC; Malheiros DA; Modanez F; Silva JD; Vieira S; Macedo AC; Massarope B; Furusawa EA; Schvartsman BG
    J Bras Nefrol; 2013; 35(3):237-41. PubMed ID: 24100744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic uremic syndrome in children.
    Talarico V; Aloe M; Monzani A; Miniero R; Bona G
    Minerva Pediatr; 2016 Dec; 68(6):441-455. PubMed ID: 27768015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Heterozygous Missense Variants in Diacylglycerol Kinase Epsilon and Complement Factor I: Potential Pathogenic Association With Atypical Hemolytic Uremic Syndrome.
    Abughanimeh OK; Baljevic M; Nester A
    Cureus; 2024 Jan; 16(1):e52633. PubMed ID: 38374836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late Onset Cobalamin Disorder and Hemolytic Uremic Syndrome: A Rare Cause of Nephrotic Syndrome.
    Ardissino G; Perrone M; Tel F; Testa S; Morrone A; Possenti I; Tagliaferri F; Dilena R; Menni F
    Case Rep Pediatr; 2017; 2017():2794060. PubMed ID: 28835862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deterioration in Clinical Status Is Not Enough to Suspend Eculizumab: A Genetic Complement-Mediated Atypical Hemolytic Uremic Syndrome Case Report.
    Calvaruso L; Naticchia A; Ferraro PM; Vischini G; Costanzi S
    Case Rep Nephrol; 2019; 2019():9264824. PubMed ID: 31360562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atypical HUS caused by complement-related abnormalities].
    Yoshida Y; Matsumoto M
    Rinsho Ketsueki; 2015 Feb; 56(2):185-93. PubMed ID: 25765799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab.
    Andries G; Karass M; Yandrapalli S; Linder K; Liu D; Nelson J; Pawar R; Chugh S
    Exp Hematol Oncol; 2017; 6():4. PubMed ID: 28101432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical hemolytic uremic syndrome: a case report.
    Basnayake BMDB; Wazil AWM; Nanayakkara N; Samarakoon SMDK; Senavirathne EMSK; Thangarajah BUEWDR; Karunasena N; Mahanama RMBSS
    J Med Case Rep; 2020 Jan; 14(1):11. PubMed ID: 31928535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical Hemolytic Uremic Syndrome Caused by a Rare Complement Factor B Mutation.
    Bandaru SS
    Cureus; 2022 Mar; 14(3):e23207. PubMed ID: 35317246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplant recurrence of atypical hemolytic uremic syndrome in a patient with thrombomodulin mutation.
    Sinibaldi S; Guzzo I; Piras R; Bresin E; Emma F; Dello Strologo L
    Pediatr Transplant; 2013 Dec; 17(8):E177-81. PubMed ID: 24118826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.
    Fakhouri F; Delmas Y; Provot F; Barbet C; Karras A; Makdassi R; Courivaud C; Rifard K; Servais A; Allard C; Besson V; Cousin M; Châtelet V; Goujon JM; Coindre JP; Laurent G; Loirat C; Frémeaux-Bacchi V
    Am J Kidney Dis; 2014 Jan; 63(1):40-8. PubMed ID: 24021908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Management of Atypical Hemolytic-Uremic Syndrome in Pregnancy Using Eculizumab: A Case Review.
    Altaf F; Khanzada M; Qasim A; Anto AM; Haider A; Khaja M
    Cureus; 2024 Apr; 16(4):e57973. PubMed ID: 38738120
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.